Phase 3CompletedAge-related condition
Age-Related Eye Disease Study (AREDS)
- Sponsor
- National Eye Institute (NEI) (NIH)
- Enrollment
- 4,757 enrolled
- Conditions
- Macular Degeneration; Cataract; Lens Opacities
- Interventions
- Antioxidants; Zinc; Antioxidants and zinc
- Ages
- adults, older adults
- Registry
- NCT00000145
Full record on ClinicalTrials.gov
From the registry
To assess the clinical course, prognosis, and risk factors of age-related macular degeneration (AMD) and cataract. To evaluate, in randomized clinical trials, the effects of pharmacologic doses of (1) antioxidants and zinc on the progression of AMD and (2) antioxidants on the development and progression of lens opacities.
Primary outcomes
- Progression of age-related macular degeneration
- Progression of lens opacity (cataract)
History
Last registry update
Study completion
Primary completion
Registered
Started
Papers citing this trial
- Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration
Journal of ophthalmology
- Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study
JAMA ophthalmology
- A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
Archives of ophthalmology (Chicago, Ill. : 1960)